↓ Skip to main content

Rimonabant—A Selective CB1 Antagonist

Overview of attention for article published in Annals of Pharmacotherapy, April 2005

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
1 X user
patent
3 patents

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Rimonabant—A Selective CB1 Antagonist
Published in
Annals of Pharmacotherapy, April 2005
DOI 10.1345/aph.1e499
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 1%
Netherlands 1 1%
Brazil 1 1%
Unknown 82 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 13 15%
Student > Master 12 14%
Student > Ph. D. Student 11 13%
Researcher 11 13%
Other 5 6%
Other 14 16%
Unknown 19 22%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 24 28%
Agricultural and Biological Sciences 12 14%
Psychology 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Biochemistry, Genetics and Molecular Biology 4 5%
Other 9 11%
Unknown 25 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2024.
All research outputs
#6,568,679
of 31,542,270 outputs
Outputs from Annals of Pharmacotherapy
#1,068
of 4,256 outputs
Outputs of similar age
#18,700
of 94,714 outputs
Outputs of similar age from Annals of Pharmacotherapy
#8
of 43 outputs
Altmetric has tracked 31,542,270 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,256 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,714 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.